A Pharmacokinetic Interaction Study of Rapamycin (Sirolimus) and SU11248 (Sunitinib) in Patients With Advanced Solid Tumors.
Phase of Trial: Phase 0
Latest Information Update: 11 Jun 2013
At a glance
- Drugs Sirolimus (Primary) ; Sunitinib (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 02 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Jan 2008 New trial record.